Skip to main content

22 November 2025

Last updated: Saturday 22 November 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

The linker matters in antibody-drug conjugates

Sunday 22 November 2020

Interviewee/Contributor

Philipp Spycher

Organisation

Araris Biotech AG

Organisations

ETH Zürich
European Biopharmaceutical Enterprises
Anavo Therapeutics BV
Bellevue Asset Management
Harvard Stem Cell Institute
MedNous contributing editor
BioLizard NV
Novasecta Ltd
Johnson & Johnson Innovation Center, London
SciTribe and BioBeat

Interviewees and Contributers

Søren Møller
Shayesteh Fürst-Ladani
Hugh Laverty
Steven D. Pearson
Angelika Joos
Ed Corbett
Graham Burnett-Hall
Andrew Hopkins
Reisa Sperling
William Sellers

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Werner Lanthaler appointed CEO of FairJourney Biologics

Thursday 6 November 2025

New CEO at Evaxion

Thursday 6 November 2025

Draig Therapeutics appoints President and CEO

Thursday 6 November 2025

Forbion appoints partner in growth fund

Thursday 6 November 2025

Amphista Therapeutics names executives to drive clinical development

Thursday 6 November 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form